Disposal of Shareholding in Hikal Ltd. by Hikal Employee Welfare Trust A & B
Hikal Ltd has informed BSE regarding "Disposal of Shareholding in Hikal Ltd. by Hikal Employee Welfare Trust A & B".12-06-2013
12-06-2013
Outcome of EGM
Hikal Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on May 17, 2013.24-05-2013
Disclosure of Voting results of EGM (Clause 35A)
Hikal Ltd has informed BSE regarding the details of Voting results at the Extra Ordinary General Meeting (EGM) of the Company held on May 17, 2013, under Clause 35A.21-05-2013
Outcome of Board Meeting
Hikal Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2013, inter alia, has transacted the following:1. Mr. Jai Hiremath, Chairman & Managing Director, has been re-appointed for a period of 5 years commencing July 01, 2013 and2. Mr. Sameer Hiremath, President & Joint Managing Director, has been re-appointed for a period of 5 years commencing July 01, 2013....16-05-2013
Board recommends Dividend
Hikal Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2013, inter alia, has recommended Dividend on Equity Share Capital @ 25% [Rs. 2.50 per equity share, (nominal value of Rs. 10 each)] for financial year 2012-13, subject to the approval of Shareholders in the ensuing Annual General Meeting.16-05-2013
Financial Results & Auditors Report for March 31, 2013 (Audited)
Hikal Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2013.16-05-2013
Board to consider Dividend
Hikal Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 16, 2013, inter alia, to consider and to take on record Audited Financial Results for the year ended March 31, 2013 & also consider recommendation of Dividend for the year ended March 31, 2013.13-05-2013
Hikals Pharmaceutical Manufacturing Site in Gujarat, India received US FDA Approval
Hikal Ltd has informed BSE regarding "Hikals Pharmaceutical Manufacturing Site in Gujarat, India received US FDA Approval".25-04-2013
EGM on May 17, 2013
Hikal Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on May 17, 2013.22-04-2013